Factors affecting protein release behavior from surfactant-protein complexes under physiological conditions

International Journal of Pharmaceutics

Volumn 338, Issue 1-2, 2007, Pages 174-179

  Yoshiura, Hiromu ^a   Hashida, Masakazu ^a   Kamiya, Noriho ^a   Goto, Masahiro ^a  

^a KYUSHU UNIVERSITY   (Japan)

Author keywords

Drug delivery; Emulsions; Peptide drug; Protein drug; Protein release; Protein stability; Surfactant protein complex

Indexed keywords

GLUCOSE OXIDASE; HORSERADISH PEROXIDASE; LYSOZYME; SUCROSE ERUCATE; SUCROSE ESTER DERIVATIVE; SUCROSE LAURATE; SUCROSE OLEATE; SURFACTANT; UNCLASSIFIED DRUG;

ARTICLE; ASPERGILLUS NIGER; CATALYSIS; COMPLEX FORMATION; DRUG DELIVERY SYSTEM; DRUG FORMULATION; EMULSION; ENZYME ACTIVITY; HYDROPHOBICITY; PRIORITY JOURNAL; PROTEIN SECRETION;

CHEMISTRY, PHARMACEUTICAL; EMULSIONS; GLUCOSE OXIDASE; MURAMIDASE; PARTICLE SIZE; PROTEINS; SOLUBILITY; SURFACE-ACTIVE AGENTS;

EID: 34248648186     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2007.01.041     Document Type: Article

References (17)

1. Calceti P., Salmaso S., Walker G., and Bernkop-Schnürch A. Development and in vivo evaluation of an oral insulin-PEG delivery system. Eur. J. Pharm. Sci. 22 (2004) 315-323
2. Courrier M.H., Pons F., Lessinger M.J., Frossard N., Krafft P.M., and Vandamme F.T. In vivo evaluation of a reverse water-in-fluorocarbon emulsion stabilized with a semifluorinated amphiphile as a drug delivery system through the pulmonary route. Int. J. Pharm. 282 (2004) 131-140
3. Graham D.E., and Phillips M.C. Proteins at liquid interfaces Ill. Molecular structures of adsorbed films. J. Colloid Interface Sci. 70 (1979) 427-439
4. Hovgaard L., Jacobs H., Wilson D.E., and Kim S.W. Stabilization of insulin by alkylmaltosides. B. Oral absorption in vivo in rats. Int. J. Pharm. 132 (1996) 115-121
5. Jørgensen L., Vermehren C., Bjerregaard S., and Froekjaer S. Secondary structure alterations in insulin and growth hormone water-in-oil emulsions. Int. J. Pharm. 254 (2003) 7-10
6. Lee Y.-H., and Sinko P.J. Oral delivery of Salmon calcitonin. Adv. Drug Deliv. Rev. 42 (2004) 225-238
7. Onuki Y., Morishita M., Takayama K., Tokiwa S., Chiba Y., Isowa K., and Nagai T. In vivo effects of highly purified docosahexaenoic acid on rectal insulin absorption. Int. J. Pharm. 198 (2000) 147-156
8. Pazur J.H., Kleppe K., and Cepure A. A glycoprotein structure for glucose oxidase from Aspergillus niger. Arch. Biochem. Biophys. 111 (1965) 351-357
9. Prego C., García M., Torres D., and Alonso J.M. Transmucosal macromolecular drug delivery. J. Control. Rel. 101 (2005) 151-162
10. Playford R.J., Ghosh S., and Mahmood A. Growth factors and trefoil peptides in gastrointestinal health and disease. Curr. Opin. Pharmacol. 4 (2004) 567-571
11. Sellak H., Franzini E., Hakim J., and Pasquier C. Mechanism of lysozyme inactivation and degradation by iron. Arch. Biochem. Biophys. 299 (1992) 172-178
12. Sood A., and Panchagnula R. Peroral route: an opportunity for protein and peptide drug delivery. Chem. Rev. 101 (2001) 3275-3303
13. Swoboda B.E.P., and Massey V. Purification and properties of the glucose oxidase from Aspergillus niger. J. Biol. Chem. 240 (1965) 2209-2215
14. Talmadge J.E. The pharmaceutics and delivery of therapeutic polypeptides and proteins. Adv. Drug Deliv. Rev. 10 (1993) 247-299
15. Toorisaka E., Ono H., Arimori K., Kamiya N., and Goto M. Hypoglycemic effect of surfactant-coated insulin solubilized in a novel solid-in-oil-in-water (S/O/W) emulsion. Int. J. Pharm. 252 (2003) 271-274
16. Toorisaka E., Hashida M., Kamiya N., Ono H., Kokazu Y., and Goto M. An enteric-coated dry emulsion formulation for oral insulin delivery. J. Control. Rel. 107 (2005) 91-96
17. Zhang N., Ping Q.N., Huang G.H., and Xu W.F. Investigation of lectin-modified insulin liposomes as carriers for oral administration. Int. J. Pharm. 294 (2005) 247-259